Prenatal and infant exposures and age at menarche

Epidemiology

Volumn 24, Issue 2, 2013, Pages 277-284

  D'Aloisio, Aimee A ^a   Deroo, Lisa A ^a   Baird, Donna D ^a   Weinberg, Clarice R ^a   Sandler, Dale P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL;

ADOLESCENT PREGNANCY; ADULT; ARTICLE; BIRTH ORDER; BIRTH WEIGHT; BODY HEIGHT; BODY WEIGHT; BREAST CANCER; CANCER RISK; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GESTATIONAL AGE; HIGH RISK PREGNANCY; HISPANIC; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MATERNAL SMOKING; MENARCHE; MENSTRUAL CYCLE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PRENATAL EXPOSURE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BREAST NEOPLASMS; CHILD; COHORT STUDIES; CONFIDENCE INTERVALS; DIABETES MELLITUS; DIETHYLSTILBESTROL; FEMALE; HUMANS; HYPERTENSION; INFANT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; LOGISTIC MODELS; MENARCHE; MIDDLE AGED; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; SIBLINGS; SMOKING;

EID: 84873411416     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31828062b7     Document Type: Article

References (56)

1. A hmed ML, Ong KK, Dunger DB. Childhood obesity and the timing of puberty. Trends Endocrinol Metab. 2009;20:237-242.
2. G olub MS, Collman GW, Foster PM, et al. Public health implications of altered puberty timing. Pediatrics. 2008;121(suppl 3):S218-S230.
3. E uling SY, Herman-Giddens ME, Lee PA, et al. Examination of US puberty- timing data from 1940 to 1994 for secular trends: panel findings. Pediatrics 2008;121(suppl 3):S172-S191.
4. Hoel DG, Wakabayashi T, Pike MC. Secular trends in the distributions of the breast cancer risk factors - menarche, first birth, menopause, and weight - in Hiroshima and Nagasaki, Japan. Am J Epidemiol. 1983;118:78-89.
5. C humlea WC, Schubert CM, Roche AF, et al. Age at menarche and racial comparisons in US girls. Pediatrics. 2003;111:110-113.
6. A nderson SE, Dallal GE, Must A. Relative weight and race influence average age at menarche: results from two nationally representative surveys of US girls studied 25 years apart. Pediatrics. 2003;111(4 Pt 1):844-850.
7. Karapanou O, Papadimitriou A. Determinants of menarche. Reprod Biol Endocrinol. 2010;8:115.
8. Windham GC, Bottomley C, Birner C, Fenster L. Age at menarche in relation to maternal use of tobacco, alcohol, coffee, and tea during pregnancy. Am J Epidemiol. 2004;159:862-871.
9. Windham GC, Zhang L, Longnecker MP, Klebanoff M. Maternal smoking, demographic and lifestyle factors in relation to daughter's age at menarche. Paediatr Perinat Epidemiol. 2008;22:551-561.
10. R ubin C, Maisonet M, Kieszak S, et al. Timing of maturation and predictors of menarche in girls enrolled in a contemporary British cohort. Paediatr Perinat Epidemiol. 2009;23:492-504.
11. Maisonet M, Christensen KY, Rubin C, et al. Role of prenatal characteristics and early growth on pubertal attainment of British girls. Pediatrics. 2010;126:e591-e600.
12. Morris DH, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ. Determinants of age at menarche in the UK: analyses from the Breakthrough Generations Study. Br J Cancer. 2010;103:1760-1764.
13. Shrestha A, Nohr EA, Bech BH, Ramlau-Hansen CH, Olsen J. Smoking and alcohol use during pregnancy and age of menarche in daughters. Hum Reprod. 2011;26:259-265.
14. Ferris JS, Flom JD, Tehranifar P, Mayne ST, Terry MB. Prenatal and childhood environmental tobacco smoke exposure and age at menarche. Paediatr Perinat Epidemiol. 2010;24:515-523.
15. R omundstad PR, Vatten LJ, Nilsen TI, et al. Birth size in relation to age at menarche and adolescent body size: implications for breast cancer risk. Int J Cancer. 2003;105:400-403.
16. Persson I, Ahlsson F, Ewald U, et al. Influence of perinatal factors on the onset of puberty in boys and girls: implications for interpretation of link with risk of long term diseases. Am J Epidemiol. 1999;150:747-755.
17. Koziel S, Jankowska EA. Effect of low versus normal birthweight on menarche in 14-year-old Polish girls. J Paediatr Child Health. 2002;38:268-271.
18. Sloboda DM, Hart R, Doherty DA, Pennell CE, Hickey M. Age at menarche: influences of prenatal and postnatal growth. J Clin Endocrinol Metab. 2007;92:46-50.
19. A dair LS. Size at birth predicts age at menarche. Pediatrics. 2001; 107:E59.
20. dos Santos Silva I, De Stavola BL, Mann V, Kuh D, Hardy R, Wadsworth ME. Prenatal factors, childhood growth trajectories and age at menarche. Int J Epidemiol. 2002;31:405-412.
21. Opdahl S, Nilsen TI, Romundstad PR, Vanky E, Carlsen SM, Vatten LJ. Association of size at birth with adolescent hormone levels, body size and age at menarche: relevance for breast cancer risk. Br J Cancer. 2008;99:201-206.
22. T erry MB, Ferris JS, Tehranifar P, Wei Y, Flom JD. Birth weight, postnatal growth, and age at menarche. Am J Epidemiol. 2009;170:72-79.
23. T am CS, de Zegher F, Garnett SP, Baur LA, Cowell CT. Opposing influences of prenatal and postnatal growth on the timing of menarche. J Clin Endocrinol Metab. 2006;91:4369-4373.
24. Blell M, Pollard TM, Pearce MS. Predictors of age at menarche in the newcastle thousand families study. J Biosoc Sci. 2008;40:563-575.
25. E pplein M, Novotny R, Daida Y, Vijayadeva V, Onaka AT, Le Marchand L. Association of maternal and intrauterine characteristics with age at menarche in a multiethnic population in Hawaii. Cancer Causes Control. 2010;21:259-268.
26. Jefferson WN, Padilla-Banks E, Newbold RR. Adverse effects on female development and reproduction in CD-1 mice following neonatal exposure to the phytoestrogen genistein at environmentally relevant doses. Biol Reprod. 2005;73:798-806.
27. Maranghi F, Tassinari R, Moracci G, Macrìc, Mantovani A. Effects of a low oral dose of diethylstilbestrol (DES) on reproductive tract development in F1 female CD-1 mice. Reprod Toxicol. 2008;26:146-150.
28. N ikaido Y, Yoshizawa K, Danbara N, et al. Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. Reprod Toxicol. 2004;18:803-811.
29. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115:e290-e296.
30. C rume TL, Ogden L, Daniels S, Hamman RF, Norris JM, Dabelea D. The impact of in utero exposure to diabetes on childhood body mass index growth trajectories: the EPOCH study. J Pediatr. 2011;158:941-946.
31. Dabelea D. The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care. 2007;30(suppl 2):S169-S174.
32. D'Aloisio AA, Baird DD, DeRoo LA, Sandler DP. Association of intrauterine and early-life exposures with diagnosis of uterine leiomyomata by 35 years of age in the Sister Study. Environ Health Perspect. 2010;118:375-381.
33. R ekkas M. Approximate inference for the multinomial logit model Stat Probabil Lett. 2009;79:237-242.
34. R aghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger P. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol. 2001;27:85-95.
35. R aghunathan TE, Solenberger PW, Van Hoewyk J. IVEware: Imputation and Variance Estimation Software. 0.1 ed. Ann Arbor, MI: Survey Methodology Program, Survey Research Center, Institute for Social Research, University of Michigan; 2009.
36. Must A, Phillips SM, Naumova EN, et al. Recall of early menstrual history and menarcheal body size: after 30 years, how well do women remember? Am J Epidemiol. 2002;155:672-679.
37. C ooper R, Blell M, Hardy R, et al. Validity of age at menarche self-reported in adulthood. J Epidemiol Community Health. 2006;60:993-997.
38. C airns BJ, Liu B, Clennell S, et al. Lifetime body size and reproductive factors: comparisons of data recorded prospectively with self reports in middle age. BMC Med Res Methodol. 2011;11:7.
39. Weinberg CR, Shore DL, Umbach DM, Sandler DP. Using risk-based sampling to enrich cohorts for endpoints, genes, and exposures. Am J Epidemiol. 2007;166:447-455.
40. Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS. Relation of age at menarche to race, time period, and anthropometric dimensions: the Bogalusa Heart Study. Pediatrics. 2002;110:e43.
41. Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics. 1997;99:505-512.
42. McDowell MA, Brody DJ, Hughes JP. Has age at menarche changed? Results from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. J Adolesc Health. 2007;40:227-231.
43. Jefferson WN, Williams CJ. Circulating levels of genistein in the neonate, apart from dose and route, predict future adverse female reproductive outcomes. Reprod Toxicol. 2011;31:272-279.
44. Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet. 1997; 350:23-27.
45. C ao Y, Calafat AM, Doerge DR, et al. Isoflavones in urine, saliva, and blood of infants: data from a pilot study on the estrogenic activity of soy formula. J Expo Sci Environ Epidemiol. 2009;19:223-234.
46. Hoey L, Rowland IR, Lloyd AS, Clarke DB, Wiseman H. Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children. Br J Nutr. 2004;91: 607-616.
47. Strom BL, Schinnar R, Ziegler EE, et al. Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood. JAMA. 2001;286:807-814.
48. A dgent MA, Daniels JL, Rogan WJ, et al. Early-life soy exposure and age at menarche. Paediatr Perinat Epidemiol. 2012;26:163-175.
49. Merritt RJ, Jenks BH. Safety of soy-based infant formulas containing isoflavones: the clinical evidence. J Nutr. 2004;134:1220S-1224S.
50. N ewbold RR. Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol Appl Pharmacol. 2004;199:142-150.
51. Bibbo M, Gill WB, Azizi F, et al. Follow-up study of male and female offspring of DES-exposed mothers. Obstet Gynecol. 1977;49:1-8.
52. Palmer JR, Hatch EE, Rosenberg CL, et al. Risk of breast cancer in women exposed to diethylstilbestrol in utero: preliminary results (United States). Cancer Causes Control. 2002;13:753-758.
53. Hatch EE, Troisi R, Wise LA, et al. Preterm birth, fetal growth, and age at menarche among women exposed prenatally to diethylstilbestrol (DES). Reprod Toxicol. 2011;31:151-157.
54. Vatten LJ, Romundstad PR, Holmen TL, Hsieh CC, Trichopoulos D, Stuver SO. Intrauterine exposure to preeclampsia and adolescent blood pressure, body size, and age at menarche in female offspring. Obstet Gynecol. 2003;101:529-533.
55. R os HS, Lichtenstein P, Ekbom A, Cnattingius S. Tall or short? Twenty years after preeclampsia exposure in utero: comparisons of final height, body mass index, waist-to-hip ratio, and age at menarche among women, exposed and unexposed to preeclampsia during fetal life. Pediatr Res. 2001;49:763-769.
56. Shrestha A, Nohr EA, Bech BH, Ramlau-Hansen CH, Olsen J. Parental age at childbirth and age of menarche in the offspring. Hum Reprod. 2010;25:799-804.